全文获取类型
收费全文 | 22270篇 |
免费 | 1985篇 |
国内免费 | 680篇 |
专业分类
耳鼻咽喉 | 253篇 |
儿科学 | 472篇 |
妇产科学 | 489篇 |
基础医学 | 2773篇 |
口腔科学 | 411篇 |
临床医学 | 1627篇 |
内科学 | 4769篇 |
皮肤病学 | 461篇 |
神经病学 | 1185篇 |
特种医学 | 354篇 |
外国民族医学 | 1篇 |
外科学 | 3148篇 |
综合类 | 2704篇 |
一般理论 | 1篇 |
预防医学 | 1293篇 |
眼科学 | 232篇 |
药学 | 2345篇 |
4篇 | |
中国医学 | 727篇 |
肿瘤学 | 1686篇 |
出版年
2024年 | 43篇 |
2023年 | 361篇 |
2022年 | 1125篇 |
2021年 | 1549篇 |
2020年 | 1097篇 |
2019年 | 1543篇 |
2018年 | 1601篇 |
2017年 | 991篇 |
2016年 | 691篇 |
2015年 | 865篇 |
2014年 | 1483篇 |
2013年 | 1351篇 |
2012年 | 1141篇 |
2011年 | 1319篇 |
2010年 | 1027篇 |
2009年 | 912篇 |
2008年 | 893篇 |
2007年 | 929篇 |
2006年 | 747篇 |
2005年 | 627篇 |
2004年 | 555篇 |
2003年 | 557篇 |
2002年 | 334篇 |
2001年 | 280篇 |
2000年 | 256篇 |
1999年 | 245篇 |
1998年 | 343篇 |
1997年 | 268篇 |
1996年 | 188篇 |
1995年 | 156篇 |
1994年 | 131篇 |
1993年 | 92篇 |
1992年 | 95篇 |
1991年 | 81篇 |
1990年 | 52篇 |
1989年 | 57篇 |
1988年 | 68篇 |
1987年 | 43篇 |
1986年 | 48篇 |
1985年 | 93篇 |
1984年 | 114篇 |
1983年 | 73篇 |
1982年 | 98篇 |
1981年 | 78篇 |
1980年 | 80篇 |
1979年 | 74篇 |
1978年 | 49篇 |
1977年 | 32篇 |
1976年 | 29篇 |
1975年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
61.
Darren S Parsons David A Reaveley Darrell V Pavitt Madhukar Misra Edwina A Brown 《Nephrology, dialysis, transplantation》2003,18(9):1848-1853
BACKGROUND: Studies have reported an increase in median Lipoprotein (Lp) (a) in patients with high molecular weight (HMW) apolipoprotein (apo) (a) isoforms and renal impairment. Some studies identify Lp (a) levels as a risk factor for vascular disease in renal failure whilst others have demonstrated an association with apo (a) isoform type and vascular disease. METHODS: A total of 239 patients at end-stage renal failure (ESRF) were studied prior to the initiation of dialysis. Blood was taken for Lp (a) levels and apo (a) isoforms. Clinical vascular disease (CVD) was assessed on the basis of clinical history and Rose questionnaire. The control group for Lp (a) levels consisted of 228 healthy volunteers. RESULTS: Despite a higher median Lp (a) level in those with HMW isoforms, 30% of patients had Lp (a) levels <10 mg/dl. Overall, 49% patients were identified as having CVD. Diabetes, smoking history and Lp (a) levels were significantly associated with CVD in logistic regression analysis, although when patients with low molecular weight (LMW) and HMW isoforms were analysed separately, Lp (a) levels were not significantly associated with CVD in those with LMW isoforms. The rates of CVD in those with HMW isoform and low Lp (a) levels were significantly lower than those with HMW isoforms and elevated Lp (a) levels, 34 vs 57% (P < 0.01). CONCLUSIONS: Although median Lp (a) levels in those patients at ESRF with HMW isoforms are higher than controls, in a third of such patients Lp (a) levels remain relatively low. These patients have lower rates of CVD than those with high levels of Lp (a). 相似文献
62.
Hidekazu Mukai Hiroshi Yoshinaga Akihiko Watanabe Hitoshi Fujiwara Tsuyoshi Fujita 《Digestive endoscopy》2004,16(Z1):S58-S61
After removal of intraductal stones, a 10‐Fr or 7‐Fr pancreatic stent was placed in 16 patients with upstream ductal dilation proximal to a stricture of the main pancreatic duct. Stents were removed after a mean duration of 52.5 days. Nine patients underwent repeated stenting. About one year after removal of the initial stent, when the remaining upstream ductal dilation was found on follow‐up pancreatograms, the next stent was replaced. Repeated stenting improved outflow of pancreatic juice more effectively than one‐time stenting. Correlation between long‐term pain relief without recurrence of intraductal stones and reduction of duct diameter was also shown. Stent occlusion was observed in 14 of 30 stents. Stent occlusion was frequently associated with recurrence of pancreatitis and intraductal stones, and was also associated with morphologic changes in the pancreatic ductal system. Although there were no significant differences between stent patency of the initial stents and that of the next stents, stent patency of 10‐Fr stents was superior to that of 7‐Fr stents. 10‐Fr stents should be removed within 8 weeks and 7‐Fr stents should be removed within 4 weeks for the prevention of stent occlusion. Repeated stenting with short‐term stenting is therefore considered a safe and effective protocol of endoscopic pancreatic stenting. 相似文献
63.
Inhibitory Effect of Angiogenesis Inhibitor TNP—470 on Human ACHN Renal Cell Carcinoma 总被引:2,自引:0,他引:2
Angiogenesis,the formation of new bloodvessels,is necessary for the growth of tumors andtheir metastasis.TNP- 470 is a synthetic analogueof fumagillin and has stronger antiangiogenic ac-tivity and less side- effects than fumagillin.Thiscompound has been reported to suppress the prolif-eration and metastasis of various kinds of tu-mors[1] . Using nude mice xenografts of ACHN hu-man renal cell carcinoma ( RCC) ,the presentstudyattempted to examine the action of TNP- 470 ongrowth,metastasi… 相似文献
64.
65.
66.
鼻息肉上皮细胞凋亡与bcl-2的表达及意义 总被引:4,自引:0,他引:4
目的 了解细胞的凋亡和癌基因bcl 2在鼻息肉的发病机制中的作用。方法 应用免疫组织化学的方法检测 45例鼻息肉细胞凋亡早期蛋白 (M3 0 )和bcl 2的表达 ,用下鼻甲粘膜作自身对照。结果 鼻息肉上皮和下鼻甲粘膜上皮的M3 0指数分别为 0 482± 0 3 2 ;1 0 62± 0 5 47,其差别有统计学意义 (P <0 0 1)。bcl 2阳性细胞在鼻息肉表层上皮和腺上皮均有表达 ,在下鼻甲中未见表达 ,其指数为 14 5 1± 4 46。结论 鼻息肉的发病机制及其生长过程与上皮细胞的增殖和凋亡的失平衡有关。bcl 2的表达可能是鼻息肉上皮凋亡抑制的原因 ,在鼻息肉上皮细胞增殖和凋亡失平衡的过程中起重要作用 相似文献
67.
Microtubule-associated protein tau is required for axonal neurite elaboration by neuroblastoma cells. 总被引:5,自引:0,他引:5
NB2a/d1 neuroblastoma cells constitutively express multiple isoforms of the microtubule-associated protein tau and incorporate this protein into the axonal neurites elaborated during serum deprivation. To examine whether or not tau played an essential role in axonal outgrowth, cells cultured in serum-free medium were treated at 24 h intervals with antisense- and sense-oriented cDNA oligonucleotides (25 or 36 mers that span or are upstream of tau initiation codon) and were simultaneously serum deprived. Oligonucleotide uptake was confirmed by determination of intracellular levels of radiolabeled oligonucleotides. Treatment for 48 h with tau antisense oligonucleotides reversibly inhibited the expression of tau and the number of neurite-bearing cells compared with treatment with sense oligonucleotides. By contrast, tubulin expression was not affected. When cells were treated with antisense oligonucleotide simultaneously with serum deprivation, the initial outgrowth of neurites was unaffected, but continued neurite elongation was prevented. By contrast, neurite outgrowth at 4 h was inhibited when cells were pretreated with tau antisense 24 h before serum deprivation. Furthermore, intracellular delivery of anti-tau antiserum prevented neurite outgrowth and, in cells that had previously been deprived of serum for 24 h, induced retraction of existing neurites. These findings indicate that both the initiation and the continued outgrowth of neurites are dependent on tau and that pre-existing cytoplasmic pools of tau can mediate initial neuritogenesis. 相似文献
68.
MAP1a is a microtubule-associated protein with an apparent molecular weight of 360 kDa that is found in the axonal and dendritic processes of neurons. Two monoclonal anti-MAP1a antibodies, anti-A and anti-BW6, revealed different epitope distributions in the adult mouse cerebellum. Anti-A stained Purkinje and granule cells uniformly throughout the cerebellum. In contrast, anti-BW6 selectively stained the dendrites of a subset of Purkinje cells, revealing parasagittal bands of immunoreactivity in the molecular layer. The compartmentation of the BW6 epitope was compared to the Purkinje cells as revealed by immunostaining with anti-zebrin II, a well known antigen expressed selectively by bands of Purkinje cells. The anti-BW6 staining pattern was complementary to the zebrin II bands, the zebrin II- Purkinje cells having BW6+ dendrites. These results demonstrate that MAP1a is present in two forms in the mouse cerebellum, one of which is segregated into parasagittal bands. This may indicate a unique MAP1a isoform or may reflect differences in the metabolic states of Purkinje cell classes, and regional differences in their functions. 相似文献
69.
Soluble CD30 in pediatric patients with atopic dermatitis 总被引:9,自引:1,他引:8
Atopic dermatitis (AD) is a chronic, inflammatory skin disease in which a pathogenetic role of Th2 cells has been supposed. This study investigated the presence of soluble CD30 (sCD30), an activation marker of T-cell clones able to produce Th2-type cytokines, in sera from pediatric patients affected by AD ( n =25) with no symptoms of asthma or rhinitis. The severity of the disease was graded by both the SCORAD and Costa et al. clinical scoring systems. Serum levels of sCD30 were significantly higher in patients with AD in respect to both normal donors ( n =20) and urticaria patients ( n = 10), and a positive correlation between serum sCD30 and clinical score was found ( r =0.508; P =0.01) when AD patients were evaluated by Costa et al.'s method. Furthermore, a significant association ( r -=0.443; P =0.027) between sCD30 and serum levels of the soluble interleukin (IL)-2 receptor (sIL-2R) was observed in AD. The presence of high amounts of sCD30 in atopic patients seems to confirm the role of this molecule as an activation marker useful for in vivo evaluation of a Th2 immune response, and the correlation observed with both clinical score and sIL-2R levels indicates the role of sCD30 as an additional marker of disease activity in pediatric patients with AD. 相似文献
70.
O. F. M. SELLEVOLD T. M. BERG K. A. REIN O. W. LEVANG O–J. IVERSEN K. BERGH 《Acta anaesthesiologica Scandinavica》1994,38(4):372-379
A prospective randomized study was performed to investigate the effect of surface coating with covalently endpoint–attached heparin (Carmeda Bio Active Surface) and reduced general heparinization on haematological indices and complement C5 activation. Care was taken to optimize the rheological design of the system using centrifugal pump and a closed system without venting or machine suction. Twenty patients scheduled for aortocoronary bypass grafting (EF > 0.5) participated in the study. Ten patients were randomized to be treated with heparin–coated equipment (CBAS) and reduced i.v. heparin (1.5 mg kg-1) while 10 patients treated with identical but noncoated equipment and full heparinization (3 mg–kg-1) served in a Control group. A vacuum suction was used to collect the blood from the operating field and it was autotransfused at weaning from extracorporeal circulation (ECC). Blood samples were obtained from the venous (precircuit) and arterial (postcircuit) side. We used a new and very specific method for detection of C5a based on monoclonal antibodies. The concentration of C5a was low in both groups during the operation but a significant increase was seen on days 1 and 2. In the Control group there was an increase from 10.2 ngml-1±1.2 to 27.5 ng ml-1 ± 4.8 on day 2 and in the CBAS group from 10.7 ng ml-1 ± 1.2 to 35.6 ng ml-1 ± 11.6 on day 2 (NS between groups). The granulocytes and total leukocyte count increased at the end of ECC and was maintained at the elevated level throughout the study period. The amount of free haemoglobin was high in the autotransfused blood in both groups. The present results confirm the feasibility of reducing general heparin when using heparin–coated systems but the study does not support the superiority of such coating with regard to biocompatibility in short procedures with a Theologically optimized circuit. The potential benefit from reduced heparin and protamine has not been fully evaluated. 相似文献